Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.
暂无分享,去创建一个
M. Tenhunen | A. Hemminki | K. Guse | V. Cerullo | Ilkka Liikanen | I. Diaconu | S. Pesonen | J. Dias | M. Eriksson | M. Savontaus | R. Grénman | Dung-tsa Chen | Petri Nokisalmi